Remus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 26-11-2023
- Paid Up Capital ₹ 1.47 Cr
as on 26-11-2023
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 Cr
as on 26-11-2023
- Revenue 32.32%
(FY 2022)
- Profit 224.12%
(FY 2022)
- Ebitda 143.92%
(FY 2022)
- Net Worth 109.24%
(FY 2022)
- Total Assets 43.96%
(FY 2022)
About Remus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.47 Cr.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Remus Pharmaceuticals Limited India are Anjali Shah SERVING AS THE CHIEF FINANCIAL OFFICER (CFO) and Deval Patel as Company Secretary. Vishrut Pathak, Swapnil Shah, Anar Shah, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232GJ2015PLC084536
- Company No.
084536
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2015
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc-Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Remus Pharmaceuticals Limited offer?
Remus Pharmaceuticals Limited offers a wide range of products and services, including Injectable Products, Pharmaceutical Injectables, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Remus Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arpit Shah  | Managing Director | 21-Sep-2015 | Current |
| Anjali Shah | CFO(Kmp) | 06-Jan-2023 | Current |
| Deval Patel | Company Secretary | 06-Jan-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishrut Pathak | Director | 06-Jan-2023 | Current |
| Swapnil Shah | Wholetime Director | 21-Sep-2015 | Current |
| Anar Shah | Wholetime Director | 20-Mar-2020 | Current |
| Balwant Purohit | Director | 06-Jan-2023 | Current |
| Sanjana Shah | Director | 06-Jan-2023 | Current |
| Roma Shah | Wholetime Director | 21-Sep-2015 | Current |
Financial Performance and Corporate Structure Insights of Remus Pharmaceuticals.
Remus Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.32% increase. The company also saw a substantial improvement in profitability, with a 224.12% increase in profit. The company's net worth Soared by an impressive increase of 109.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Remus Pharmaceuticals?
Unlock access to Remus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Senores Pharmaceuticals LimitedActive 6 years 11 monthsSwapnil Shah and Arpit Shah are mutual person
Relius Lifesciences Private LimitedActive 8 years 27 daysSwapnil Shah, Anar Shah and 2 more are mutual person
Ratnatris Pharmaceuticals Private LimitedActive 18 years 11 monthsSwapnil Shah and Arpit Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 29 Oct 2022 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Remus Pharmaceuticals?
Remus Pharmaceuticals has a workforce of 34 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Remus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
